Tobacco users' perceptions of a brief tobacco cessation intervention in community pharmacies.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 3023976)

Published in J Am Pharm Assoc (2003) on September 13, 2010

Authors

Pallavi D Patwardhan1, Betty A Chewning

Author Affiliations

1: Schroeder Institute for Tobacco Research and Policy Studies, American Legacy Foundation, Washington, DC 20036, USA. ppatwardhan@legacyforhealth.org

Articles cited by this

Annual smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 1997-2001. MMWR Morb Mortal Wkly Rep (2005) 8.10

Cigarette smoking among adults--United States, 2007. MMWR Morb Mortal Wkly Rep (2008) 6.82

What to do with a patient who smokes. JAMA (2005) 4.11

Qualitative study of patients' perceptions of doctors' advice to quit smoking: implications for opportunistic health promotion. BMJ (1998) 3.03

Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med (2003) 2.00

Tobacco cessation counseling: pharmacists' opinions and practices. Patient Educ Couns (2006) 1.86

An evaluation of smoking cessation-related activities by pharmacists. J Am Pharm Assoc (Wash) (2000) 1.71

Healthy People 2010: challenges, opportunities, and a call to action for America's pharmacists. Pharmacotherapy (2004) 1.71

Qualitative study investigating the process of giving anti-smoking advice in general practice. Patient Educ Couns (2004) 1.67

Feedback from community pharmacy users on the contribution of community pharmacy to improving the public's health: a systematic review of the peer reviewed and non-peer reviewed literature 1990-2002. Health Expect (2004) 1.43

Evaluation of community pharmacy service mix: evidence from the 2004 National Pharmacist Workforce Study. J Am Pharm Assoc (2003) (2006) 1.42

Patient perceptions of tobacco cessation services in dental offices. J Am Dent Assoc (1999) 1.34

Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation. Ann Pharmacother (2009) 1.26

Using interpersonal perception to characterize pharmacists' and patients' perceptions of the benefits of pharmaceutical care. Health Commun (2005) 1.21

The pharmacist's role in smoking cessation counseling: perceptions of users of nonprescription nicotine replacement therapy. J Am Pharm Assoc (2003) (2003) 1.20

Tobacco interventions delivered by pharmacists: a summary and systematic review. Pharmacotherapy (2007) 1.15

Does health habit counseling affect patient satisfaction? Prev Med (2001) 1.11

A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction (2001) 1.10

Smoking-cessation services in Iowa community pharmacies. Pharmacotherapy (2003) 0.96

Costs and effects associated with a community pharmacy-based smoking-cessation programme. Pharmacoeconomics (1998) 0.95

Ask, advise and refer: hypothesis generation to promote a brief tobacco-cessation intervention in community pharmacies. Int J Pharm Pract (2009) 0.94

An unfortunate and avoidable component of American pharmacy: tobacco. Am J Pharm Educ (2008) 0.93

Smoking cessation activities by pharmacists in East Texas. J Am Pharm Assoc (Wash) (2002) 0.89

Views of Ontarians about health professionals' smoking cessation advice. Can J Public Health (2007) 0.87

Patients' views of pharmacists as providers of smoking cessation services. J Am Pharm Assoc (Wash) (2002) 0.85

Creating a road map for pharmacy's role in the cessation of tobacco use. Am J Health Syst Pharm (2006) 0.82

Articles by these authors

Practitioner empathy and the duration of the common cold. Fam Med (2009) 1.33

Role theory: literature review and implications for patient-pharmacist interactions. Res Social Adm Pharm (2005) 1.33

Effect of a tobacco cessation continuing professional education program on pharmacists' confidence, skills, and practice-change behaviors. J Am Pharm Assoc (2003) (2010) 1.29

Self-management, knowledge, and functioning and well-being of patients on hemodialysis. Nephrol Nurs J (2004) 1.03

Older patient, physician and pharmacist perspectives about community pharmacists' roles. Int J Pharm Pract (2012) 1.02

Provision of risk management and risk assessment information: the role of the pharmacist. Res Social Adm Pharm (2006) 1.01

Recall of A1C, blood pressure, and cholesterol levels among community pharmacy patients with diabetes. J Am Pharm Assoc (2003) (2007) 1.01

Ask, advise and refer: hypothesis generation to promote a brief tobacco-cessation intervention in community pharmacies. Int J Pharm Pract (2009) 0.94

Effectiveness of intervention to implement tobacco cessation counseling in community chain pharmacies. J Am Pharm Assoc (2003) (2012) 0.93

Depressive symptoms and reduced preventive care use in older adults: the mediating role of perceived access. Med Care (2012) 0.91

Development of a measure to assess pharmacy students' beliefs about monitoring chronic diseases. Res Social Adm Pharm (2008) 0.86

A randomized controlled trial to evaluate the impact of structured patient interactions on pharmacy students' counselling behaviours and attitudes. Int J Pharm Pract (2009) 0.83

Quality of care for older adults with chronic obstructive pulmonary disease and asthma based on comparisons to practice guidelines and smoking status. BMC Health Serv Res (2008) 0.80

Patient and phaRmacist telephonic encounters (PARTE) in an underserved rural patient population with asthma: results of a pilot study. Telemed J E Health (2012) 0.80

Predictors of pharmacy students' intentions to monitor diabetes. J Pharm Pharm Sci (2009) 0.79

Evaluating pharmacists' ability to counsel on tobacco cessation using two standardized patient scenarios. Patient Educ Couns (2011) 0.79

Patient And phaRmacist Telephonic Encounters (PARTE) in an underserved rural population with asthma: methods and rationale. Inov Pharm (2011) 0.76

Evaluation of structured patient interactions: the Diabetes Check. Am J Pharm Educ (2006) 0.75

Sources of drug information for patients with chronic conditions in Alexandria, Egypt. Int J Pharm Pract (2010) 0.75